All In Biotech

Free tool

FAERS Monitor: Photofrin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020451 or its brand name (Photofrin, Porfimer Sodium). Reports on generic versions are filed under their own applications.

Reports

341

Serious

313

92% of reports

Hospitalization

103

Death reported

74

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use72
  • cholangitis42
  • oesophageal stenosis28
  • dyspnoea19
  • hypotension19
  • sepsis15
  • photosensitivity reaction14
  • pneumonia14
  • post procedural complication14
  • swelling face13
  • deep vein thrombosis12
  • fatigue11
  • nausea11
  • pyrexia11
  • atrial fibrillation10

Reports by year received

View as table
YearReports
20045
200517
200633
200731
20087
200916
201018
20115
201252
201322
201412
201530
201623
201715
20187
201910
20201
20218
20224
20235
20247
20257
20265

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,818 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
oesophageal stenosisSignal28613.3429.216,348
cholangitisSignal42420.7316.617,057
photosensitivity reactionSignal1452.331.3655
post procedural complicationSignal1445.026.9559
swelling faceSignal1312.37.2124
deep vein thrombosisSignal1211.46.5104
sepsisSignal158.35.190
atrial fibrillationSignal106.33.440
hypotensionSignal195.83.872
off label useSignal725.14.1241
pneumoniaSignal142.71.613
dyspnoeaSignal192.11.310
pyrexia112.01.14
fatigue110.90.50
nausea110.90.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.